Transformation of Thyroid Eye Disease Phenotype Following Teprotumumab Treatment

Julie M Shabto1, Shanlee Stevens, Celestine Gregerson

  • 1Department of Ophthalmology, Irving Medical Center, Edward S. Harkness Eye Institute, Columbia University, New York City, New York, U.S.A.